Intravenous Alpha-1 Antitrypsin Therapy for Critically Ill COVID-19 Patients

Isr Med Assoc J. 2022 Jul;24(7):441-443.

Authors

Ori Wand^{1

2}, David Dahan^{1

2}, Naveh Tov³, Gali Epstein Shochet^{1

2}, Daniel A King^{1

2}, David Shitrit^{1

2}

Affiliations

¹ Department of Pulmonary Medicine, Meir Medical Center, Kfar Saba, Israel.
² Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Department of Clinical Development, Kamada Ltd, Rehovot, Israel.

PMID: 35819210

No abstract available

MeSH terms

COVID-19*
Critical Illness / therapy
Humans
alpha 1-Antitrypsin Deficiency* / complications
alpha 1-Antitrypsin Deficiency* / drug therapy